您的位置: 首页 > 农业专利 > 详情页

azaindole derivatives which act as pi3k inhibitors
专利权人:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人:
EDCON CHANG,MICHAEL B. WALLACE,WOLFGANG REINHARD LUDWIG NOTZ
申请号:
BR112015000386
公开号:
BR112015000386A2
申请日:
2013.07.08
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
abstract disclosed are compounds of formula 1, and pharmaceutically acceptable salts thereof, wherein r1, r2, r3, r4, r5, r6, r7, r8, r9, and r10 are defined in the specification. this disclosure also relates to materials and methods for preparing compounds of formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with pi3kd. p3kd-5004-wo translation of the abstract summary "azaindole derivatives which act as pi3k inhibitors" are disclosed compounds of formula 1, and pharmaceutically acceptable salts thereof, wherein r1, r2, r3, r4, r5, r6, r7, r8, r9 and r10 are defined in the descriptive report. This disclosure also relates to materials and methods for preparing compounds of formula 1, pharmaceutical compositions which contain them and their use to treat immune disorders, cardiovascular disease, cancer and other diseases, disorders or conditions associated with pi3kd.abstract disclosed are compounds of formula 1, , and pharmaceutically acceptable salts thereof, wherein r1, r2, r3, r4, r5, r6, r7, r8, r9, and r10 are defined in the specification. this disclosure also relates to materials and methods for preparing compounds of formula 1, to pharmaceutical compositions which contain them, and to their use for treating immunological disorders, cardiovascular disease, cancer, and other diseases, disorders or conditions associated with pi3kd. p3kd-5004-wo tradução do resumo resumo "derivados de azaindol os quais agem como inibidores de pi3k" são divulgados compostos de fórmula 1, , e sais farmaceuticamente aceitáveis dos mesmos, em que r1, r2, r3, r4, r5, r6, r7, r8, r9 e r10 são definidos no relatório descritivo. esta divulgação também se refere a materiais e métodos para preparar compostos de fórmula 1, a composições farmacêuticas as quais os contêm e a seu uso para tratar distúrbios imunológicos, doença cardiovascular, c
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充